Professor Chloe Orkin is Professor of Infection and Inequities at Queen Mary University of London and Consultant Physician at Barts Health NHS Trust. She specialises in therapeutics and has contributed to the licensing of medicines for HIV, viral hepatitis, and SARS-CoV-2. She is the global lead author for the first-ever long-acting injectable HIV therapy. Chloe is an expert advisor to WHO Europe on mpox and COVID-19. During the multi-country mpox (monkeypox) outbreaks she established and led an international collaborative clinical network (SHARE-net) resulting in three global case series on mpox infection. She is the Academic Lead for Equality Diversity and Inclusion in the Faculty of Medicine at QMUL. She directs the QMUL-based SHARE research collaborative for health equity. Chloe is the 80th President of the Medical Women's Federation, past Chair of the British HIV Association, on the governing council for the International AIDS Society and a scientific advisor to the Medicines Patent Pool.